Global Botanical And Plant-Derived Drugs Market, By Source (Plant, Algae, Macroscopic fungi, and Others), By Dosage Form (Pills, Tablets, Capsules, and Injection), By Therapeutic Application (Central Nervous System, Cardiovascular Diseases, Infectious Diseases, and Respiratory Diseases), By Region (North America, Latin America, Europe, Middle East, Asia Pacific, Africa) - Trends, Analysis and Forecast till 2029

Botanical drugs are derived from medicinal plants. These plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs and plant derived drugs are an important component of traditional medicine and therapies, which include homeopathy and ayurvedic medicines. The major classes of plant drugs are steroids, terpenes, phenols, and glycosides. Botanical drugs are available in various forms, such as tablets, pills, capsules and injections.

North America dominates the global botanical and plant-derived drugs market and is expected to maintain its dominancy over the forecast period owing to rising awareness towards botanical and plant derived drugs and increasing prevalence of diseases, in the region.

The markets in Asia Pacific and Europe are expected to show significant growth rates in global botanical and plant-derived drugs market. This can be attributed to growing technological advancement in production procedure of botanical is also supporting in the region.

Moreover, increasing number of chronic disease across the globe is a major factor driving growth of the global botanical and plant-derived drugs market.

However, stringent laws and regulations for approval of botanical drugs is a major factor expected to hamper growth of the global botanical and plant-derived drugs market over the forecast period. 

The global botanical and plant-derived drugs market has been segmented on the basis of source, dosage form, therapeutic application, and region. The source segment includes plant, algae, macroscopic fungi, and others. On the basis of dosage form the global botanical and plant-derived drugs market has been segmented pills, tablets, capsules, and injection. The therapeutic application segment includes central nervous system, cardiovascular diseases, infectious diseases, and respiratory diseases.

On the basis of region the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is expected to account major market share as compared to that of other regions.

Key players operating in the global botanical and plant-derived drugs market includes Bayer Healthcare, GlaxoSmithKline, Pfizer,Inc., Sanofi, Actelion Pharmaceuticals, Aimil Pharmaceuticals, Allergan, AstraZeneca, Boehringer Ingelheim, and GW Pharmaceuticals.